Cancer Communications

Articles

Content type: Original article
| 10 October 2018

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Authors: Wei Wei, Pei-En Jian, Shao-Hua Li, Zhi-Xing Guo, Yong-Fa Zhang, Yi-Hong Ling, Xiao-Jun Lin, Li Xu, Ming Shi, Lie Zheng, Min-Shan Chen and Rong-Ping Guo
Content type: Original article
| 26 September 2018

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response

Authors: Feifei Zhang, Wenjie Wang, Yuan Long, Hui Liu, Jijun Cheng, Lin Guo, Rongyu Li, Chao Meng, Shan Yu, Qingchuan Zhao, Shun Lu, Lili Wang, Haitao Wang and Danyi Wen
Content type: Original article
| 25 September 2018

Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies

Authors: Chaofeng Li, Bingzhong Jing, Liangru Ke, Bin Li, Weixiong Xia, Caisheng He, Chaonan Qian, Chong Zhao, Haiqiang Mai, Mingyuan Chen, Kajia Cao, Haoyuan Mo, Ling Guo, Qiuyan Chen, Linquan Tang, Wenze Qiu…
Content type: Original article
| 25 September 2018

Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2

Authors: Yi Sang, Chun Cheng, Yi-Xin Zeng and Tiebang Kang
Content type: Letter to the Editor
| 24 September 2018

Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells

Authors: Lei Zhou, Dandan Sheng, Qiaodan Deng, Dong Wang and Suling Liu

Most recent articles RSS

View all articles

Content type: Review
| 2 July 2015

Predictive biomarkers in precision medicine and drug development against lung cancer

Authors: Bingliang Fang, Reza J Mehran, John V Heymach and Stephen G Swisher
Content type: Original article
| 10 August 2015

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Authors: Xue-Yan Zhang, Ge Zhang, Ying Jiang, Dan Liu, Man-Zhi Li, Qian Zhong, Shan-Qi Zeng, Wan-Li Liu and Mu-Sheng Zeng
Content type: Original article
| 12 August 2015

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Authors: Lu-Jun Shen, Si-Yang Wang, Guo-Feng Xie, Qi Zeng, Chen Chen, An-Nan Dong, Zhi-Mei Huang, Chang-Chuan Pan, Yun-Fei Xia and Pei-Hong Wu
Content type: Original article
| 15 August 2015

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Authors: Huixin Ming, Ying Lan, Feng He, Xue Xiao, Xiaoying Zhou, Zhe Zhang, Ping Li and Guangwu Huang
Content type: Review
| 7 April 2016

Cell-free circulating tumor DNA in cancer

Authors: Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang

Most accessed articles RSS

View all articles

2018

Thematic series
Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

2017

Thematic series
Tumor Metastasis
Edited by Jian Zhang and Chao-Nan Qian

2016

Thematic series
Gastric Cancer
Edited by Yun Dai and Li Yan

Thematic series
Tumor Angiogenesis
Edited by Francesco Pezzella and Chao-Nan Qian

2015

Thematic series
Lung Cancer
Edited by Lin Yan and Wei Zhang

Archival content

To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.

Important notice

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1^st March 2018.

Thematic series

Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

Tumor metastasis
Edited by: Jian Zhang and Chao-Nan Qian

Aims and scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.

Editor-in-Chief

Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Information for authors

Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.

Cancer Communications

Articles

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response

Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies

Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2

Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells

Predictive biomarkers in precision medicine and drug development against lung cancer

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Cell-free circulating tumor DNA in cancer

2018

2017

2016

2015

Archival content

Important notice

Thematic series

Aims and scope

Editor-in-Chief

Information for authors

Affiliated with

Follow

2017 Journal Metrics

Cancer Communications

Contact us